Evaluation of efficacy and safety of compound tretinoin gel in treatment of acne vulgaris
王爱平,吴艳,崔盘根,宗文凯,李春阳,焦健,顾军,闫明,李若瑜
DOI: https://doi.org/10.3969/j.issn.1674-1293.2008.03.009
2008-01-01
Abstract:Objective Evaluation of efficacy and safety of compound tretinoin gel in the treatment of acne vulgaris. Methods A randomized,double-blind,parallel study was conducted,tretinoin 0.025% cream as a control,applied once per night for 8 weeks. Efficacy was determined by counting the acne lesions (papules,pustules and comedones) before drug administration and every second week during the treatment period. Results Of 240 recruited patients,236 were appraisable for efficacy and safety. For inflammatory lesion (papules and pustules),the clinical response rates was 18.6% in the trial group and 21.2% in the control group at 2 weeks,41.5% versus 44.9% at 4 weeks respectively,64.4% versus 69.5% at 6 weeks respectively,82.2% versus 79.7% at 8 weeks respectively,and no statistical difference was observed between the two groups. For noninflammatory lesion(comedones),the clinical response rates was 5.3% in the trial group and 5.5% in the control group at 2 weeks,19.5% versus 24.6% at 4 weeks respectively,43.4% versus 50.9% at 6 weeks respectively,59.3% versus 66.4% at 8 weeks respectively,and no statistical difference was observed between the two groups. Transient and mild location skin irritation (erythema,burning,pruritus,scaling and dryness of the skin)occurred,but was well tolerated by the patients,the reaction rate of the trial group(64.1%) was higher significantly than the control group (32.2%,P=0.000). One patient in the trial group experienced moderately severe adverse event (0.9%),stopped using the drugs. Conclusion Compound tretinoin gel was as effective and safety as tretinoin 0.025% cream in acne vulgaris.